The role of genomics in the management of advanced bladder cancer.
about
Gemcitabine-(5'-phosphoramidate)-[anti-IGF-1R]: molecular design, synthetic organic chemistry reactions, and antineoplastic cytotoxic potency in populations of pulmonary adenocarcinoma (A549)Comprehensive genomic profiling of 295 cases of clinically advanced urothelial carcinoma of the urinary bladder reveals a high frequency of clinically relevant genomic alterations.Afatinib-based combination regimens for the treatment of solid tumors: rationale, emerging strategies and recent progress.Metastatic Bladder Cancer: Second-Line Treatment and Recommendations of the Genitourinary Tumor Division of the Galician Oncologic Society (SOG-GU).The New Age of -omics in Urothelial Cancer - Re-wording Its Diagnosis and Treatment.
P2860
The role of genomics in the management of advanced bladder cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
The role of genomics in the management of advanced bladder cancer.
@en
type
label
The role of genomics in the management of advanced bladder cancer.
@en
prefLabel
The role of genomics in the management of advanced bladder cancer.
@en
P2860
P1476
The role of genomics in the management of advanced bladder cancer.
@en
P2093
Elizabeth A Guancial
P2860
P2888
P356
10.1007/S11864-014-0319-Z
P577
2015-01-01T00:00:00Z
P5875
P6179
1013477583